Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
138.7 USD | -0.57% | +3.95% | +11.76% |
Mar. 26 | Dexcom Insider Sold Shares Worth $579,180, According to a Recent SEC Filing | MT |
Mar. 14 | Dexcom Insider Sold Shares Worth $10,802,803, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 4.33B | Sales 2025 * | 5.15B | Capitalization | 53.77B |
---|---|---|---|---|---|
Net income 2024 * | 673M | Net income 2025 * | 882M | EV / Sales 2024 * | 12.8 x |
Net Debt 2024 * | 1.51B | Net Debt 2025 * | 980M | EV / Sales 2025 * | 10.6 x |
P/E ratio 2024 * |
83.8
x | P/E ratio 2025 * |
65.1
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.23% |
Latest transcript on DexCom, Inc.
1 day | -0.18% | ||
1 week | +4.40% | ||
Current month | +21.04% | ||
1 month | +21.94% | ||
3 months | +12.18% | ||
6 months | +45.90% | ||
Current year | +12.24% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 18 M€ | +7.01% | - | |
1.04% | 17 M€ | -0.46% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 138.7 | -0.57% | 2 473 078 |
24-03-27 | 139.5 | -0.32% | 2,031,775 |
24-03-26 | 139.9 | -0.12% | 3,096,190 |
24-03-25 | 140.1 | +5.20% | 3,917,443 |
24-03-22 | 133.2 | -0.17% | 1,426,253 |
Delayed Quote Nasdaq, March 28, 2024 at 01:16 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.24% | 53.77B | |
+2.91% | 197B | |
+5.86% | 115B | |
+1.37% | 71.22B | |
+17.75% | 48.75B | |
+6.87% | 44.22B | |
+12.54% | 28.85B | |
+10.18% | 28.57B | |
+10.35% | 27.62B | |
+19.41% | 27.62B |